Akira Ohtori

Title: Akira Ohtori: Innovator in Pharmaceutical Composition

Introduction

Akira Ohtori is a notable inventor based in Kobe, Japan, recognized for his contributions to pharmaceutical innovations. He holds a total of eight patents, showcasing his expertise in developing advanced medical formulations.

Latest Patents

One of his latest patents is a pharmaceutical composition containing prostaglandin. The objective of this invention is to provide a stable aqueous pharmaceutical composition that suppresses the degradation of prostaglandin F in preparations. This is achieved by formulating a prostaglandin F derivative into an oil-in-water emulsion combined with an oil, such as medium-chain fatty acid triglyceride, a water-soluble polymer, and water. Another significant patent is a percutaneously absorptive ophthalmic preparation comprising olopatadine. This invention aims to prevent or treat allergic eye disease by applying a preparation that allows olopatadine to transfer effectively from the skin surface, including the eyelid, to the anterior ocular segment, providing prolonged pharmacological effects with a single application.

Career Highlights

Throughout his career, Akira Ohtori has worked with prominent companies in the pharmaceutical industry, including Senju Pharmaceutical Co., Ltd. and A. H. Robins Company, Incorporated. His work has significantly impacted the development of innovative treatments in the field of ophthalmology and beyond.

Collaborations

Some of his notable coworkers include Yasushi Morita and Masako Andoh, who have contributed to his research and development efforts.

Conclusion

Akira Ohtori's innovative work in pharmaceutical compositions has led to significant advancements in medical treatments, particularly in the area of eye care. His patents reflect a commitment to improving patient outcomes through effective and stable formulations.